Related Experiment Video

Updated: Jul 11, 2026

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets
08:50

Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets

Published on: July 3, 2018

Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test

Yi-Ching Tung1, Jing-Sheng Lee, Wen-Yu Tsai

  • 1Department of Pediatrics, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan.

European Journal of Pediatrics
|September 18, 2007
PubMed

Insights

The 6-minute glucagon test effectively assesses beta-cell function in children. This test helps differentiate type 1 diabetes from type 2 diabetes by measuring C-peptide levels.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus Research

Background:

  • Distinguishing between type 1 and type 2 diabetes in children is crucial for appropriate management.
  • Beta-cell function, assessed by C-peptide levels, plays a key role in diabetes diagnosis and monitoring.
  • Previous methods for assessing beta-cell reserve in pediatric populations have limitations.

Purpose of the Study:

  • To evaluate the efficacy of a 6-minute glucagon stimulation test in assessing beta-cell function in Taiwanese children.
  • To determine the utility of this test in differentiating between type 1 and type 2 diabetes mellitus in pediatric patients.
  • To establish optimal C-peptide cut-off values for differential diagnosis.

Main Methods:

  • A cohort of 118 Taiwanese children with newly diagnosed diabetes mellitus (98 type 1, 20 type 2) and 29 healthy controls were studied.
  • Intravenous glucagon (30 µg/kg, max 1 mg) was administered, and C-peptide levels were measured before and 6 minutes after stimulation.
  • Fasting and post-glucagon C-peptide levels were analyzed, and receiver operating characteristic (ROC) curves were used to determine diagnostic cut-offs.

Main Results:

  • Both fasting and post-glucagon C-peptide levels were significantly lower in children with type 1 diabetes compared to normal children and those with type 2 diabetes.
  • Optimal cut-off values for distinguishing type 1 from type 2 diabetes were identified as 0.7 nmol/l (fasting) and 1.1 nmol/l (post-glucagon), with 93% sensitivity for both.
  • The post-glucagon C-peptide level demonstrated higher specificity (95%) in differentiating type 1 from type 2 diabetes compared to fasting levels (85%).

Conclusions:

  • The 6-minute glucagon test is a valuable tool for assessing residual beta-cell function in children with diabetes mellitus.
  • This test aids pediatricians in the differential diagnosis of diabetes in children, particularly in distinguishing type 1 from type 2 diabetes.
  • The findings support the use of the glucagon stimulation test for improved diagnostic accuracy in pediatric diabetes.

More Related Videos

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets09:31

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...